BPC-157 for Gut Healing
An experimental gastric peptide with promising research for healing ulcers, IBD, and intestinal damage
Quick Answer
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Animal research shows remarkable healing effects on ulcers, intestinal anastomosis, fistulas, and inflammatory bowel disease. It was tested in phase II clinical trials for ulcerative colitis with a "very safe profile." BPC-157 can be taken orally and remains stable in stomach acid. While promising for gut healing, it remains experimental with limited human data. Typical oral dosing in research translates to approximately 250-500mcg 1-2x daily.
Emerging
New research, promising but early
Safety: BPC-157 has shown a very safe profile in animal studies and limited human trials for IBD, but remains experimental. No serious adverse effects documented, but long-term human safety data is limited.
What Is This?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide, a chain of 15 amino acids, derived from a protective protein found in human gastric juice.
What makes it unique:
- Stable in human gastric juice (unlike most peptides, which degrade in stomach acid)
- Can be taken orally or by injection
- Shows broad healing effects across multiple tissue types
- Has completed phase II clinical trials for IBD
- Gastric and duodenal ulcer healing
- Inflammatory bowel disease (ulcerative colitis, Crohn's)
- Intestinal anastomosis healing (surgical connections)
- Fistula healing
- NSAID-induced GI damage protection
- Short bowel syndrome
How It Works
Cytoprotective Mechanisms: BPC-157 demonstrates what researchers call "cytoprotection", protecting cells from damage. Unlike standard cytoprotective agents that only work preventatively, BPC-157 shows both prophylactic AND therapeutic ability.
Angiogenesis and Endothelium: The peptide promotes new blood vessel formation (angiogenesis) and protects blood vessel lining (endothelium). This is critical for healing damaged gut tissue, which requires robust blood supply for repair.
Nitric Oxide System: BPC-157 interacts with the nitric oxide system, which regulates blood flow, inflammation, and tissue repair. Studies show it can normalize NO levels that become dysregulated in inflammatory conditions.
Gene Expression: Research shows BPC-157 stimulates expression of early growth response 1 (EGR-1) gene, which activates cytokine and growth factor production and promotes early collagen formation, all essential for wound healing.
IBD Research: In ulcerative colitis models, BPC-157 showed rapid cytoprotective endothelium rescue against disabled vessels, restoring blood supply and normalizing oxidative stress markers. It was described as offering "a more effective class of cytoprotective agents."
Anastomosis and Fistula Healing: Animal studies showed BPC-157 successfully heals intestinal anastomoses and various fistulas (gastrocutaneous, duodenocutaneous, colocutaneous). Remarkably, fistula closure was achieved even when therapy was delayed for one month.
How to Start
Understand the experimental nature
BPC-157 is not an approved drug or supplement. Using it involves accepting uncertainty about long-term safety, sourcing quality, and optimal dosing. Consider whether you have exhausted conventional treatments first.
Tips:
- •Most human safety data comes from limited clinical trials for IBD
- •No serious adverse effects have been documented, but data is limited
- •Consult with a knowledgeable practitioner if possible
- •This is more appropriate for those who have tried standard treatments without success
Source high-quality BPC-157
Quality varies dramatically among suppliers. Seek pharmaceutical-grade product from reputable sources. Some compounding pharmacies produce BPC-157. Third-party testing for purity is important.
Tips:
- •Compounding pharmacies may offer higher quality assurance
- •Look for third-party purity testing (HPLC analysis)
- •Avoid extremely cheap sources, purity is likely compromised
- •BPC-157 arginate (salt form) may be more stable for oral use
Determine dosing
Animal research used doses that translate to approximately 200-500mcg for humans when scaled by body weight. Some practitioners recommend 250-500mcg once or twice daily taken orally on an empty stomach.
Tips:
- •Oral administration is effective, BPC-157 is stable in stomach acid
- •Taking on empty stomach may improve absorption
- •Lower doses (250mcg) are reasonable starting points
- •Duration of use varies, some use for 4-8 weeks, others longer
Monitor and assess
Track your symptoms and any changes. Improvements in gut symptoms may occur within days to weeks based on animal research showing rapid effects. Discontinue if any adverse effects occur.
Tips:
- •Keep a symptom journal to track changes
- •Animal research shows effects can be quite rapid
- •If no improvement after 4-8 weeks, reassess
- •Some people cycle on and off rather than using continuously
What to Expect
Initial phase
Based on animal research showing rapid effects, some people report improvements in gut symptoms within the first week. Others may not notice changes immediately.
Potential healing effects
If BPC-157 is helping, improvements in digestive comfort, reduced bloating, and better bowel function may become more apparent. Ulcer-related symptoms may improve.
Assessment period
By 4-8 weeks, you should have a sense of whether BPC-157 is providing benefit. Some people continue longer; others discontinue and assess if improvements persist.
Maintenance considerations
Long-term use protocols are not established. Some practitioners recommend cycling (using for a period, then stopping). The goal is healing, not indefinite use.
Practical Details
Timing
Typically taken on an empty stomach, 1-2 times daily. Some protocols suggest taking 20-30 minutes before meals.
Duration
Duration is not established. Research protocols varied from single doses to extended treatment. Many users take it for 4-12 weeks, then reassess.
Cost
$50-$150/month
Cost varies by source and quality. Compounding pharmacy sources tend to be more expensive but may offer better quality assurance. Research chemical sources are cheaper but quality is uncertain.
Risks & Considerations
Potential Risks
- •Limited human safety data for long-term use
- •Product quality and purity concerns from unregulated sources
- •Unknown interactions with other medications
- •Regulatory uncertainty, not approved for any medical use
Possible Side Effects
- •Side effects appear rare based on available data
- •Clinical trials for IBD reported "very safe profile" with no toxicity
- •Anecdotally, some report mild nausea when starting
- •Theoretical concerns about promoting blood vessel growth in wrong contexts
Who Should Avoid This
- •History of cancer or active malignancy (angiogenic effects are a theoretical concern)
- •Pregnancy or breastfeeding (no safety data)
- •Those unwilling to accept experimental status
- •When conventional treatments have not been tried
Key Research
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Current Pharmaceutical Design, 2011
Comprehensive review found BPC-157 effective for ulcer healing, anastomosis repair, fistula healing, and short bowel syndrome in animal models. Described as anti-ulcer peptidergic agent stable in human gastric juice, effective in upper and lower GI tract, free of side effects.
View StudyFocus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
Current Medicinal Chemistry, 2012
Review of BPC-157 for IBD found very safe profile in clinical trials (PL-10, PLD-116, PL14736). Mechanism involves NO-system interaction, endothelium protection, and angiogenic effects. Stimulates EGR-1 gene for growth factor generation and collagen formation.
View StudyStable Gastric Pentadecapeptide BPC 157 and Wound Healing
Frontiers in Pharmacology, 2021
Review of BPC-157 wound healing effects across tissues. Found it promotes angiogenesis, modulates growth factors, and accelerates healing in various injury models including GI tract. Safe with no toxicity reported.
View StudyFrequently Asked Questions
Is BPC-157 legal?
BPC-157 occupies a regulatory gray area. It is not approved as a drug or dietary supplement. It is sold as a "research chemical" or through compounding pharmacies. Legality varies by jurisdiction and intended use.
Can I take BPC-157 orally or does it need to be injected?
BPC-157 is unusually stable in gastric juice, meaning it can be taken orally and remain active. Both oral and injectable forms are used. For gut-specific issues, oral administration makes logical sense as the peptide reaches the GI tract directly.
How does BPC-157 compare to L-glutamine for gut healing?
L-glutamine is a well-established amino acid that supports gut lining integrity with extensive safety data. BPC-157 appears more potent in animal models but has far less human data. Many people use both. L-glutamine is much cheaper and more accessible.
Are there concerns about promoting cancer growth?
BPC-157 promotes angiogenesis (blood vessel growth), which theoretically could support tumor growth. There is no direct evidence of this, but those with active cancer or history of cancer should exercise extreme caution and consult oncologists.
Sources
Related Interventions
Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any new health practice or supplement. Evidence levels and recommendations can change, this content was last updated December 2025.